Walker J A, Ewald T J, Lewallen E, Van Wijnen A, Hanssen A D, Morrey B F, Morrey M E, Abdel M P, Sanchez-Sotelo J
Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Bone Joint Res. 2017 Mar;6(3):162-171. doi: 10.1302/2046-3758.63.BJR-2016-0193.
Sustained intra-articular delivery of pharmacological agents is an attractive modality but requires use of a safe carrier that would not induce cartilage damage or fibrosis. Collagen scaffolds are widely available and could be used intra-articularly, but no investigation has looked at the safety of collagen scaffolds within synovial joints. The aim of this study was to determine the safety of collagen scaffold implantation in a validated animal model of knee arthrofibrosis.
A total of 96 rabbits were randomly and equally assigned to four different groups: arthrotomy alone; arthrotomy and collagen scaffold placement; contracture surgery; and contracture surgery and collagen scaffold placement. Animals were killed in equal numbers at 72 hours, two weeks, eight weeks, and 24 weeks. Joint contracture was measured, and cartilage and synovial samples underwent histological analysis.
Animals that underwent arthrotomy had equivalent joint contractures regardless of scaffold implantation (-13.9° -10.9°, equivalence limit 15°). Animals that underwent surgery to induce contracture did not demonstrate equivalent joint contractures with (41.8°) or without (53.9°) collagen scaffold implantation. Chondral damage occurred in similar rates with (11 of 48) and without (nine of 48) scaffold implantation. No significant difference in synovitis was noted between groups. Absorption of the collagen scaffold occurred within eight weeks in all animals CONCLUSION: Our data suggest that intra-articular implantation of a collagen sponge does not induce synovitis or cartilage damage. Implantation in a native joint does not seem to induce contracture. Implantation of the collagen sponge in a rabbit knee model of contracture may decrease the severity of the contracture. J. A. Walker, T. J. Ewald, E. Lewallen, A. Van Wijnen, A. D. Hanssen, B. F. Morrey, M. E. Morrey, M. P. Abdel, J. Sanchez-Sotelo. Intra-articular implantation of collagen scaffold carriers is safe in both native and arthrofibrotic rabbit knee joints. 2016;6:162-171. DOI: 10.1302/2046-3758.63.BJR-2016-0193.
药物的持续关节内递送是一种有吸引力的方式,但需要使用不会引起软骨损伤或纤维化的安全载体。胶原支架广泛可得且可用于关节内,但尚无研究探讨滑膜关节内胶原支架的安全性。本研究的目的是在经过验证的膝关节纤维性关节病动物模型中确定胶原支架植入的安全性。
总共96只兔子被随机且等分为四组:单纯关节切开术;关节切开术并放置胶原支架;挛缩手术;挛缩手术并放置胶原支架。在72小时、两周、八周和24周时以相等数量处死动物。测量关节挛缩情况,并对软骨和滑膜样本进行组织学分析。
接受关节切开术的动物,无论是否植入支架,关节挛缩情况相当(-13.9° -10.9°,等效界限15°)。接受诱导挛缩手术的动物,植入(41.8°)或未植入(53.9°)胶原支架时,关节挛缩情况并不相当。植入(48只中的11只)和未植入(48只中的9只)支架时软骨损伤发生率相似。各实验组间滑膜炎无显著差异。所有动物在八周内胶原支架均被吸收。结论:我们的数据表明,关节内植入胶原海绵不会引起滑膜炎或软骨损伤。在正常关节内植入似乎不会导致挛缩。在兔膝关节挛缩模型中植入胶原海绵可能会减轻挛缩的严重程度。J.A.沃克、T.J.埃瓦尔德、E.卢瓦伦、A.范维嫩、A.D.汉森、B.F.莫里、M.E.莫里、M.P.阿卜杜勒、J.桑切斯 - 索特洛。胶原支架载体在正常和纤维性关节病兔膝关节内的关节内植入都是安全的。2016年;6:162 - 171。DOI: 10.1302/2046 - 3758.63.BJR - 2016 - 0193。